Ultromics is a pioneer in AI-driven cardiology diagnostics solutions, offering the first FDA-cleared, Medicare-reimbursed AI technology to help clinicians detect Heart Failure with Preserved Ejection Fraction (HFpEF) and cardiac amyloidosis.
Investment Rounds
Capital activity and funding progression
Industries
Frequently Asked Questions
What industries does Ultromics operate in?
Ultromics operates in the following industries: Healthcare, AI, Cardiology.
When was Ultromics founded?
Ultromics was founded on 2025-07-31.
How much total funding has Ultromics raised?
Ultromics has raised a total of $55,000,000.
Who are the investors in Ultromics?
The investors in Ultromics are: Oxford Science Enterprises, GV, Blue Venture Fund, University of Chicago Medicine, UPMC Enterprises, Lightrock, Allegis Capital.
Who are the founders of Ultromics?
The founders of Ultromics are: PhD.